Come up with a name for your new list and we'll add to it:
Anelixis Therapeutics raised a round of funding on June 20, 2017. Investors include
Realise Capital Partners.
Anelixis Therapeutics was formed in 2013 and is a for-profit subsidiary of ALS Therapy Development Institute (ALSTDI), a nonprofit biotechnology organization dedicated to developing effective treatmen…